ANIK

Anika Therapeutics, Inc. NASDAQ

Healthcare ·Medical - Devices ·US · anikatherapeutics.com

$14.55

Mkt Cap $195.0M

52w Low $7.87 79.8% of range 52w High $16.24

50d MA $14.31 200d MA $10.70

P/E (TTM) -19.5x

EV/EBITDA -57.0x

P/B 1.5x

Debt/Equity 0.2x

ROE -7.6%

P/FCF 31.6x

RSI (14) —

ATR (14) —

Beta 0.28

50d MA $14.31

200d MA $10.70

Avg Volume 144.0K

About

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic a…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 29, 2026	TNS	-0.07	0.27	+485.7%	12.39	+2.4%	+0.5%	+19.9%	+17.4%	—	—	—
Feb 26, 2026	TNS	-0.12	0.31	+348.0%	12.79	-0.9%	+12.3%	+12.0%	+12.6%	+12.3%	+11.4%	—
Nov 5, 2025	TNS	0.02	0.04	+100.0%	9.85	+0.2%	-1.0%	+0.0%	+2.2%	+2.8%	+2.5%	—
Jul 30, 2025	TNS	-0.13	-0.13	+0.0%	8.10	+0.0%	+2.0%	+6.7%	+8.3%	+3.1%	+1.9%	—
May 9, 2025	TNS	0.09	-0.06	-166.7%	11.64	+5.0%	+1.8%	+6.6%	-2.7%	+5.2%	+4.7%	—
Mar 12, 2025	TNS	-0.01	-0.03	-200.0%	17.11	-4.1%	-11.1%	-7.0%	-5.8%	-7.3%	-6.8%	—
Oct 31, 2024	TNS	0.30	-0.25	-183.3%	17.11	+0.4%	-3.4%	-0.2%	-4.7%	+0.9%	+0.7%	—
Aug 8, 2024	TNS	0.23	0.17	-26.1%	25.68	-1.9%	+0.0%	-2.4%	-2.6%	-1.5%	-0.5%	—
May 8, 2024	TNS	-0.19	-0.31	-63.2%	28.47	-5.5%	-11.3%	-10.0%	-10.2%	-10.1%	-8.4%	—
Mar 13, 2024	TNS	-0.26	-4.30	-1553.8%	25.40	-6.0%	-3.4%	+0.2%	-0.5%	-0.1%	+0.7%	—
Nov 2, 2023	TNS	-0.33	-0.45	-36.4%	18.99	+27.5%	+11.2%	+11.6%	+10.5%	+9.2%	+7.4%	—
Aug 8, 2023	TNS	-0.34	-0.19	+44.1%	21.05	+1.4%	-4.9%	-11.8%	-12.7%	-8.7%	-12.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 27	Barrington Research	Maintains	Outperform → Outperform	—	$12.79	$12.67	-0.9%	+12.3%	+12.0%	+12.6%	+12.3%	+11.4%
Jan 9	Barrington Research	Maintains	Outperform → Outperform	—	$9.55	$9.58	+0.3%	-0.3%	-1.5%	+0.0%	-0.1%	-0.2%
Nov 6	Barrington Research	Maintains	Outperform → Outperform	—	$9.85	$9.87	+0.2%	-1.0%	+0.0%	+2.2%	+2.8%	+2.5%
Sep 23	Barrington Research	Maintains	Outperform → Outperform	—	$9.34	$9.34	+0.0%	-2.4%	-2.9%	-3.6%	-3.4%	-2.1%
Jul 31	Barrington Research	Maintains	Outperform → Outperform	—	$8.10	$8.10	+0.0%	+2.0%	+6.7%	+8.3%	+3.1%	+1.9%
May 12	Barrington Research	Maintains	Outperform → Outperform	—	$11.64	$12.22	+5.0%	+1.8%	+6.6%	-2.7%	+5.2%	+4.7%
Mar 13	Barrington Research	Maintains	Outperform → Outperform	—	$17.11	$16.41	-4.1%	-11.1%	-7.0%	-5.8%	-7.3%	-6.8%
Nov 1	Barrington Research	Maintains	Outperform → Outperform	—	$17.11	$17.18	+0.4%	-3.4%	-0.2%	-4.7%	+0.9%	+0.7%
Oct 22	Barrington Research	Maintains	Outperform → Outperform	—	$24.44	$24.48	+0.2%	+1.1%	+0.4%	+0.3%	-0.5%	+0.9%
Aug 9	Barrington Research	Maintains	Outperform → Outperform	—	$25.68	$25.19	-1.9%	+0.0%	-2.4%	-2.6%	-1.5%	-0.5%
May 29	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$24.76	$24.96	+0.8%	+3.6%	+3.8%	+3.6%	+7.8%	+6.6%
May 9	Barrington Research	Maintains	Outperform → Outperform	—	$28.47	$26.91	-5.5%	-11.3%	-10.0%	-10.2%	-10.1%	-8.4%
Mar 14	Barrington Research	Maintains	Outperform → Outperform	—	$25.40	$23.87	-6.0%	-3.4%	+0.2%	-0.5%	-0.1%	+0.7%
Mar 14	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$25.40	$23.87	-6.0%	-3.4%	+0.2%	-0.5%	-0.1%	+0.7%
Jan 3	Barrington Research	Maintains	Outperform → Outperform	—	$22.66	$22.59	-0.3%	-0.1%	-2.0%	-2.6%	-0.2%	-0.9%
Nov 3	Barrington Research	Maintains	Outperform → Outperform	—	$18.99	$24.21	+27.5%	+11.2%	+11.6%	+10.5%	+9.2%	+7.4%
Aug 14	Barrington Research	Upgrade	Market Perform → Outperform	—	$18.38	$19.40	+5.5%	+4.5%	+0.7%	+0.7%	+0.5%	+2.3%
Aug 10	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$20.01	$20.00	-0.1%	-7.2%	-8.1%	-4.0%	-7.5%	-7.5%
May 31	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$27.06	$26.97	-0.3%	+0.1%	-1.3%	+0.8%	-1.2%	-0.4%
Mar 7	Barrington Research	Downgrade	Outperform → Market Perform	—	$28.87	$27.63	-4.3%	-10.3%	-6.0%	-6.8%	-9.6%	-9.8%
Nov 9	Barrington Research	Upgrade	Market Perform → Outperform	—	$27.37	$28.21	+3.1%	+8.1%	+16.6%	+13.5%	+12.6%	+14.2%
Mar 9	Stephens & Co.	Downgrade	Overweight → Equal Weight	—	$30.60	$28.75	-6.0%	-14.3%	-19.3%	-16.4%	-16.8%	-17.1%
Dec 16	Barrington Research	Upgrade	Market Perform → Outperform	—	$39.27	$41.39	+5.4%	+4.3%	+7.1%	+14.1%	+9.0%	+12.4%
Jan 21	Sidoti & Co.	Upgrade	Neutral → Buy	—	$45.43	$46.60	+2.6%	+1.0%	+0.6%	+1.2%	-3.4%	-2.1%
Sep 23	First Analysis	Downgrade	Strong Buy → Outperform	—	$53.12	$51.86	-2.4%	-0.4%	-0.7%	-0.0%	+0.6%	+1.5%
Feb 22	Sidoti & Co.	Downgrade	Buy → Neutral	—	$40.49	$37.27	-8.0%	-16.2%	-17.6%	-19.7%	-18.0%	-19.4%
Jul 27	Barrington Research	Upgrade	Market Perform → Outperform	—	$40.68	$42.45	+4.4%	-1.5%	-3.1%	-1.6%	-0.4%	-0.3%
Jun 20	First Analysis	Downgrade	Overweight → Equal Weight	—	$46.12	$33.32	-27.8%	-37.6%	-35.5%	-32.8%	-33.5%	-31.8%
May 4	Barrington Research	Upgrade	Market Perform → Outperform	—	$34.80	$36.14	+3.9%	+8.8%	+9.3%	+5.6%	+5.2%	+6.3%
Feb 23	Barrington Research	Downgrade	Outperform → Market Perform	—	$57.71	$49.02	-15.1%	-10.4%	-7.6%	-6.0%	-9.8%	-10.7%
Jan 24	First Analysis	Upgrade	Equal Weight → Overweight	—	$59.38	$60.00	+1.0%	+3.5%	+5.1%	+14.1%	+15.2%	+14.9%
Apr 27	Northland Capital Markets	Downgrade	Outperform → Market Perform	—	$46.71	$45.91	-1.7%	-4.4%	+0.5%	-2.2%	-2.4%	-4.3%
Apr 27	Northland Securities	Downgrade	Outperform → Market Perform	—	$46.71	$45.91	-1.7%	-4.4%	+0.5%	-2.2%	-2.4%	-4.3%
Feb 26	Northland Securities	Maintains	Outperform → Outperform	—	$43.37	$43.47	+0.2%	+7.0%	+4.1%	+3.7%	+3.3%	+4.9%
Feb 26	Northland Capital Markets	Maintains	Outperform → Outperform	—	$43.37	$43.47	+0.2%	+7.0%	+4.1%	+3.7%	+3.3%	+4.9%

Recent Filings

8-K

Anika Therapeutics Inc -- 8-K Filing

Anika Therapeutics retains an executive in a modified role with maintained compensation but suspended vacation accrual, suggesting cost-containment measures during operational changes.

Feb 26

Data updated apr 24, 2026 6:10pm · Source: massive.com